Company Description

Spyre Therapeutics, formerly Aeglea BioTherapeutics, is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection.